Interpace Biosciences, Inc. (IDXG)
OTCMKTS
· Delayed Price · Currency is USD
1.720
-0.030 (-1.71%)
Mar 9, 2026, 3:52 PM EST
Interpace Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 48 | 12 | 5 | 4 | 31 | 13 | Upgrade
|
| Market Cap Growth | 1662.50% | 152.98% | 5.76% | -85.77% | 145.72% | -33.55% | Upgrade
|
| Enterprise Value | 49 | 63 | 60 | 58 | 87 | 53 | Upgrade
|
| Last Close Price | 1.74 | 2.70 | 1.08 | 1.04 | 7.47 | 3.14 | Upgrade
|
| PE Ratio | 16.04 | 1.90 | 2.40 | - | - | - | Upgrade
|
| PS Ratio | 1.15 | 0.25 | 0.12 | 0.14 | 0.94 | 0.39 | Upgrade
|
| PB Ratio | -161.70 | -5.35 | -0.52 | -0.27 | 7.57 | 0.73 | Upgrade
|
| P/FCF Ratio | 10.88 | 3.15 | 1.41 | - | - | - | Upgrade
|
| P/OCF Ratio | 9.88 | 2.56 | 1.24 | - | - | - | Upgrade
|
| EV/Sales Ratio | 1.17 | 1.35 | 1.49 | 1.82 | 2.62 | 1.63 | Upgrade
|
| EV/EBITDA Ratio | 8.76 | 7.55 | 11.97 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 10.73 | 7.83 | 15.07 | - | - | - | Upgrade
|
| EV/FCF Ratio | 11.07 | 16.84 | 18.00 | - | - | - | Upgrade
|
| Debt / Equity Ratio | -7.58 | -2.64 | -1.24 | -0.97 | 2.60 | 0.27 | Upgrade
|
| Debt / EBITDA Ratio | 0.40 | 0.64 | 1.93 | - | 34.59 | - | Upgrade
|
| Debt / FCF Ratio | 0.51 | 1.55 | 3.37 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -2.81 | -1.98 | -0.85 | -0.68 | 1.96 | 0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.17 | 0.52 | 1.54 | -8.80 | -20.65 | -0.11 | Upgrade
|
| Net Debt / FCF Ratio | 0.19 | 1.17 | 2.32 | -1.40 | -0.89 | -0.13 | Upgrade
|
| Asset Turnover | 3.22 | 3.36 | 2.75 | 1.17 | 0.79 | 0.67 | Upgrade
|
| Inventory Turnover | 13.70 | 13.95 | 12.22 | 13.28 | 9.95 | 11.18 | Upgrade
|
| Quick Ratio | 1.24 | 0.94 | 0.75 | 0.69 | 0.47 | 0.59 | Upgrade
|
| Current Ratio | 1.54 | 1.11 | 0.91 | 0.85 | 0.78 | 0.78 | Upgrade
|
| Return on Equity (ROE) | - | - | - | - | -65.25% | -133.86% | Upgrade
|
| Return on Assets (ROA) | 21.90% | 36.32% | 17.03% | -8.82% | -8.57% | -30.83% | Upgrade
|
| Return on Invested Capital (ROIC) | 462.35% | 1864.97% | - | -111.35% | -36.49% | -104.49% | Upgrade
|
| Return on Capital Employed (ROCE) | 75.00% | 194.10% | 235.90% | -226.40% | -25.30% | -87.40% | Upgrade
|
| Earnings Yield | 6.92% | 56.45% | 41.64% | -494.86% | -47.92% | -208.43% | Upgrade
|
| FCF Yield | 9.19% | 31.75% | 70.72% | -180.61% | -29.10% | -122.56% | Upgrade
|
| Buyback Yield / Dilution | -654.43% | -260.54% | -2.97% | -2.49% | -2.63% | -7.56% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.